The Somavert market is witnessing steady growth over the forecast period, supported by rising awareness of rare endocrine disorders, expansion of long-term injectable therapies.
Read More
The Sogroya market is witnessing steady growth over the forecast period, supported by increasing demand for simplified hormone replacement regimens, rising focus on quality-of-life improvement.
Read More
The Skytrofa market is witnessing steady growth over the forecast period, supported by increasing demand for patient-friendly growth hormone options, rising investments in long-acting biologics.
Read More
The Skysona market is witnessing steady growth over the forecast period, supported by increasing approvals of gene therapies, rising investment in rare disease pipelines.
Read More
The Skyrizi market is witnessing steady growth over the forecast period, supported by increasing expansion into new inflammatory indications, rising investments in next-generation biologics.
Read More
The Simulect market is witnessing steady growth over the forecast period, supported by growth in transplant waiting lists, expansion of transplant centers.
Read More
The Simponi, Simponi Aria (Golimumab) market is witnessing steady growth over the forecast period, supported by growth in autoimmune patient population, increasing biologic reimbursement coverage.
Read More
The Siliq market is witnessing steady growth over the forecast period, supported by increasing demand for next-generation biologics, rising focus on long-term disease management.
Read More
The Shingrix (Zostavax) market is witnessing steady growth over the forecast period, supported by increasing adult vaccination coverage targets, rising healthcare spending on preventive care.
Read More
The Rylaze market is witnessing steady growth over the forecast period, supported by increasing investments in pediatric oncology drugs, rising demand for safer leukemia treatments.
Read More